Navigation Links
Professor Patrick G. Johnston Awarded Society for Translational Oncology's Pinedo Prize
Date:5/30/2013

Durham, NC (PRWEB) May 30, 2013

The Society for Translational Oncology (STO) is pleased to announce that Professor Patrick G. Johnston, M.D., Ph.D, Dean of the School of Medicine, Dentistry & Biomedical Sciences, Queen’s University Belfast, Northern Ireland, has been named recipient of the 2013 Bob Pinedo Cancer Care Prize. The award recognizes Prof. Johnston’s pioneering work in translating discovery science for the benefit of cancer patients. His determination and leadership in establishing a Comprehensive Cancer Care and Research Program in Northern Ireland is testament to his dedication to improving both clinical outcomes and quality of life for cancer patients.

This year's Pinedo Prize of $50,000 will be presented at the STO Fourth Annual meeting, to be hosted by the VU University Medical Center Cancer Center Amsterdam (VUmc CCA) at the ING House in Amsterdam, The Netherlands, October 1, 2013. Prof. Johnston will deliver the keynote lecture at the meeting which will be published by The Oncologist, STO's official journal.

In 2012, the success of his overarching vision was recognized when he was honored to accept a Diamond Jubilee Queen’s Anniversary Prize awarded by Her Majesty, The Queen, for The Queen’s University Belfast-led Comprehensive Cancer Centre and its achievement in reducing cancer mortality rates over the last decade. This significant improvement in cancer outcomes, underpinned by best quality care and innovative research, is a direct result of Prof. Johnston’s philosophy of placing the cancer patient at the center of the cancer care and research agenda.

“I am delighted and humbled to have been awarded The Pinedo Prize,” commented Prof. Johnston. “It is a great honor to have my work and that of my research team recognized by the international cancer research community in this way.”

Prof. Johnston’s research has focused on understanding the cellular signaling pathways in gastrointestinal tumors (with a particular emphasis on colorectal cancer) and using this information as a foundation to identify novel prognostics and diagnostic biomarkers, and molecular targets to rationalize and improve patient care. His many significant papers on both cytotoxic and targeted therapies have expanded knowledge of the treatment of colorectal cancer and provided new insights on mechanisms of drug resistance.

“Patrick Johnston exemplifies the caring and gifted physician and spectacular scientific leader who will carry oncology forward into the age of rational therapeutics,” commented Dr. Bruce Chabner, editor-in-chief of The Oncologist. “Since his early days of training at the National Cancer Institute, he has distinguished himself as a forceful advocate for investigation at the bedside, a commitment that has become the watchword of his stewardship of the Queen’s University medical faculty. His own work in the area of colon cancer biology and treatment sets the highest standard for his colleagues at Belfast and in the international community of cancer research."

Among his many professional activities, Prof. Johnston is currently on the Cancer Research UK Scientific Executive Board. He is a member of the Medical Research Council (MRC) Strategy Board and Chair of the MRC Translational Research Group. He is a Founder and Director of Almac Diagnostics. He is a member of the American Society for Clinical Oncology Scientific Program Committee, Chair of International Academy for Advanced Oncology, Japan, and Board Member of Medical Schools Council UK. As a Senior Editor for The Oncologist, Co-Editor of The Oncologist European Edition, and Co-Chairman of the Society for Translational Oncology, Prof. Johnston advocates for ways to speed the discovery and translation of important new treatments in the field of cancer medicine to the practice of global oncology.

The Pinedo Cancer Care Prize honors Professor H.M. (Bob) Pinedo, founder of the VU University Medical Center (VUmc) Cancer Center Amsterdam (CCA), who weds world-class cancer research with a devotion to his patients and their families. In the past seven years, The Bob Pinedo Cancer Care Prize has been awarded to:

  •     Bruce Chabner, MD – Massachusetts General Hospital Cancer Center
  •     Joseph Bertino, MD – The Cancer Institute of New Jersey
  •     Bob Löwenberg, MD – Erasmus University Medical Centre
  •     Richard O’Reilly, MD – Memorial Sloan-Kettering Cancer Center
  •     José Baselga, MD, PhD – Massachusetts General Hospital Cancer Center
  •     Gabriel N. Hortobágyi, MD – The University of Texas MD Anderson Cancer Center
  •     Richard L. Schilsky, MD – The University of Chicago Medical Center

Nominations for the 2014 Pinedo Prize will be received by email to the Nominating Committee: Pinedo(dot)Prize(at)STO-online(dot)org until February 1, 2014. All nominations will be evaluated by an international jury.

# # #

About the Society for Translational Oncology
STO is a non-profit, tax exempt association whose mission is to speed the discovery and translation of important new treatments in the field of cancer medicine to the practice of global oncology. STO brings knowledge and strategies for critical new developments in cancer treatment to the practice of the community oncologist. For more information, visit: http://www.sto-online.org.

About The Oncologist
Recognized as a premier peer-reviewed cancer medicine journal, The Oncologist, now in its eighteenth year, is devoted to physicians entrusted with the care of cancer patients. The Oncologist is the official publication of the Society for Translational Oncology. For more information, visit: http://www.theoncologist.com.

About the Queen’s University Belfast
Ranked in the top one per cent of universities in the world (QS World University Rankings), Queen’s University Belfast was founded in 1845 as Queen's College Belfast, one of three Queen's Colleges in Ireland. Queen’s became an independent university in 1908 and is the ninth oldest university in the UK.

Queen’s is a member of the Russell Group of the UK’s leading research-intensive universities. Queen’s places a strong emphasis on international collaboration, forging partnerships with leading research groups throughout the world, including Georgetown University and Lombardi Cancer Centre, Washington; Petronas, Malaysia; a Science Bridge scheme with leading universities in China; and Infosys, one of India’s top technology companies. Priority development areas include health sciences, executive education and green chemistry.

A new £175m Institute of Health Sciences is recruiting the world’s best thinkers, innovators, scientists and clinicians to Queen’s.

For more information, visit: http://www.qub.ac.uk

For more information, contact:
Gabby Cruze, Executive Director, STO
Tel: (919) 433-0489
gabby(dot)cruze(at)sto-online(dot)org

Kevin Mulhern, Head of Communications and External Affairs
Tel: +44 (0)28 9097 3259
k(dot)mulhern(at)qub(dot)ac(dot)uk

Read the full story at http://www.prweb.com/releases/2013/5/prweb10785465.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Professor collaborates on most comprehensive analyses of NSAIDs and coxibs
2. Sofia U Professor, Author and LGBTQ Activist Judy Grahn Wins 2013 Independent Publisher Book Award
3. American Academy of Arts and Sciences elects 3 UC San Diego professors
4. Professor Ibrahim Gambari appointed KWASU’S Chancellor
5. Sofia University Professor Karen Erlichman to Co-Lead Spiritual Directors International Leadership Institute 2013
6. TGen professor discusses benefits of whole genome sequencing in study of multiple myeloma
7. GW professor researching ways to improve human tissue dissection, reduce blood transfusions
8. CWRU professor offers lessons from abroad on caring for a graying population
9. University of Houston psychology professor honored with Lifetime Distinguished Career Award
10. South Carolina College of Pharmacy professors receive awards
11. Rutgers professor recognized for revolutionizing agriculture
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... Russ DiGilio ... the first national #QuackGivesBack campaign which supported local breast cancer organizations during National ... Quack Gives Back initiative, and we’re very pleased with the participation ...
(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for dental ... Your Mouth?” (WIYM) campaign to inform dentists and patients about the safety issues related ... and prosthetic market in the U.S. is projected to reach $6.4 billion in 2018 ...
(Date:12/8/2016)... ... December 08, 2016 , ... Catalent Pharma Solutions, ... biologics and consumer health products, today announced that it had joined the Pharmaceutical ... a non-profit organization to unite pharmaceutical and healthcare companies that share a vision ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... Care Act. Dr. Botelho advocates for the mass media launching of story movements ... ongoing opportunities to share their unfortunate experiences; such a movement can generate the ...
(Date:12/8/2016)... ... December 08, 2016 , ... Peter Zipp Insurance, an ... around the greater Phoenix metropolitan region, is announcing a charity event to provide ... the Homeless Youth Connection is to promote community awareness of the ongoing needs ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 8, 2016 Research and Markets has announced ... their offering. ... The global chromatography market to grow at a ... Market 2016-2020, has been prepared based on an in-depth market analysis with ... growth prospects over the coming years. The report also includes a discussion ...
(Date:12/8/2016)... , December 8, 2016 ... "Sugar-Based Excipients Market by Product (Actual Sugars, Sugar ... (Filler & Diluent, Tonicity Agents), Formulation (Oral, Topical, ... MarketsandMarkets, the market has witnessed healthy growth during ... at a CAGR of 4.3% between 2016 and ...
(Date:12/8/2016)... , Dec. 8, 2016  Agenovir Corporation, a ... novel antiviral therapeutics, today announced that it appointed ... officer and a member of the board of ... executive with a deep background in both founding ... founder of Agenovir, co-president of Chan Zuckerberg  Biohub ...
Breaking Medicine Technology: